Stop Calling It “Chronic Fatigue”: The Physiology Behind hEDS, POTS, MCAS, and CCI
- Marcia Cristiane Perretto
- 8 hours ago
- 4 min read
It is not tiredness. It is physiology.

“Chronic fatigue” is one of the most misleading phrases in modern medicine. For people living with hypermobile Ehlers‑Danlos syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), and cervical instability including craniocervical instability (CCI), fatigue is not a motivation problem, a sleep issue, or a conditioning failure. It is the downstream result of breakdowns in autonomic blood flow, immune signaling, metabolism, and mechanical nervous system regulation.
When clinicians stop at the label “fatigue,” the real drivers of disability disappear. Patients are pushed toward graded exercise, generic strengthening, or behavioral reframing that ignores the biology involved. If the failing system is never identified, treatment will miss the mark.
This article explains why fatigue in these conditions is physiological, how the mechanisms differ, and what evidence-based care actually needs to address.
Why “Chronic Fatigue” Is a Misleading Diagnosis
Fatigue is a symptom, not a diagnosis. In hEDS, POTS, MCAS, and CCI, fatigue reflects system failure rather than low energy reserves. Grouping these patients under a vague fatigue label obscures the fact that entirely different mechanisms may be at play.
Precision matters. A person with autonomic blood flow failure requires a different strategy than someone with neuroimmune suppression or mechanical brainstem stress. Treating all fatigue as the same condition guarantees poor outcomes.
Dysautonomia and POTS: Fatigue as Blood Flow Failure
In dysautonomia, and particularly in POTS, fatigue is primarily a problem of circulation and autonomic regulation. When upright, the autonomic nervous system fails to maintain adequate venous return and cerebral perfusion. Blood pools in the lower extremities and splanchnic circulation, stroke volume drops, and cardiac output becomes insufficient.
Clinically, this shows up as:
Orthostatic tachycardia and lightheadedness
Brain fog, visual changes, and pressure headaches
Persistent sympathetic overactivation
Profound exhaustion after minimal upright activity such as showering or standing
This is not sleepiness. It is the brain operating under reduced blood flow. Hypovolemia, impaired baroreflex sensitivity, connective tissue–related venous pooling, and small fiber autonomic neuropathy all contribute. Effective care focuses on restoring cardiovascular stability, not pushing through symptoms.
Post-Exertional Malaise: A Metabolic and Neuroimmune Crash
Post‑exertional malaise (PEM) is a delayed and disproportionate worsening of symptoms following physical, cognitive, or emotional exertion. Symptoms typically peak 12 to 48 hours later and include flu-like exhaustion, cognitive impairment, dizziness, and sensory hypersensitivity.
This pattern reflects abnormal cellular energy metabolism, autonomic instability, and neuroimmune activation. It is increasingly recognized in ME/CFS, long COVID, dysautonomia, and hEDS.
Why this matters clinically:
Graded exercise therapy can worsen outcomes
Repeated crashes reinforce metabolic and autonomic injury
What helps instead:
Heart-rate guided pacing
Energy budgeting and metabolic protection
Stabilizing autonomic function before progression
MCAS: Fatigue Driven by Inflammation and Neurochemistry
In Mast Cell Activation Syndrome (MCAS), fatigue is driven by inflammatory mediators rather than poor conditioning. Mast cells release histamine, prostaglandins, leukotrienes, and cytokines that directly affect the nervous system and mitochondrial function.
Histamine alters wakefulness and autonomic tone. Cytokines suppress energy production and drive neuroinflammation. The result is sudden exhaustion, muscle burning, migraines, and cognitive fog that appear out of proportion to activity.
Common patterns include:
Sudden fatigue crashes
Heavy or weak muscles
Worsening symptoms with food, temperature, or stress
This fatigue cannot be overcome with willpower. It requires mast cell stabilization, trigger management, and autonomic support.
Cervical Instability and CCI: Mechanical Fatigue of the Nervous System
In hEDS, ligament laxity can destabilize the upper cervical spine. Craniocervical instability alters brainstem mechanics, impairs venous outflow, disrupts breathing patterns, and destabilizes autonomic regulation.
The brainstem houses critical autonomic nuclei controlling heart rate, blood pressure, respiration, and arousal. Mechanical strain or venous congestion forces the nervous system into constant fight-or-flight, dramatically increasing metabolic demand while reducing efficiency.
This creates fatigue through:
Persistent sympathetic activation
Impaired cerebral perfusion and drainage
Inefficient breathing and motor control
Rehabilitation must address cervical mechanics, proprioception, breathing, and autonomic regulation. Strength without control increases nervous system load and often worsens fatigue.
Why Treating All Fatigue the Same Fails
When fatigue is treated as a single entity, patients are blamed for not responding. In reality, different systems are failing:
Dysautonomia → cardiovascular and autonomic instability
PEM → metabolic and neuroimmune dysfunction
MCAS → inflammatory and neurochemical suppression
CCI → mechanical and neurological stress
Each requires a different strategy. Lumping them together ensures mismanagement.
What Evidence-Based Treatment Actually Addresses
Effective care is not about pushing harder. It is about restoring regulation.
Dysautonomia: fluids, salt, compression, recumbent and autonomic-informed rehabilitation
PEM: pacing, heart-rate guided activity, metabolic protection
MCAS: mast cell stabilization and inflammatory control
CCI: mechanical stabilization, breathing retraining, proprioceptive rehabilitation, venous outflow optimization
This is active, precise, and biologically grounded care.
Final Takeaway
Stop calling it “chronic fatigue.”Name the system that is failing.
When we do, patients stop being blamed and finally start receiving care that matches their physiology.
References
Centers for Disease Control and Prevention. (2023). Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.cdc.gov/me-cfs
Dysautonomia International. (n.d.). Postural orthostatic tachycardia syndrome (POTS). https://www.dysautonomiainternational.org/page.php?ID=30
Henderson, F. C., Francomano, C. A., Koby, M., Tuchman, K., & Adcock, J. (2017). Neurological and spinal manifestations of the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175(1), 195–211. https://doi.org/10.1002/ajmg.c.31549
National Institute of Neurological Disorders and Stroke. (n.d.). Postural orthostatic tachycardia syndrome (POTS). https://www.ninds.nih.gov/health-information/disorders/postural-orthostatic-tachycardia-syndrome-pots
Raj, S. R. (2013). Postural tachycardia syndrome (POTS). Circulation, 127(23), 2336–2342. https://doi.org/10.1161/CIRCULATIONAHA.112.144501
The Mast Cell Disease Society. (n.d.). Mast cell activation syndrome. https://tmsforacure.org
Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment.
.png)